UNSPSC 51161572: Nivimedone sodium anhydrous

This classification denotes a mast cell stabilizer with the molecular formula C11H8NO4.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 50HX07BAJU, chemically known as 1h-indene-1,3(2h)-dione, 5,6-dimethyl-2-nitro-, ion(1-), sodium (1:1), but more generally known as nivimedone sodium anhydrous, which bears US NIH Compound Identifier 64752. European Medicines Agency schedules nivimedone sodium anhydrous or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09333MIG.

Most nations, for tariff purposes, schedule nivimedone sodium anhydrous under HS 29147000. SMILES: CC1CC2C(CC1C)C(=O)C(=[N+]([O-])[O-])C2=O.[NA+].

UNSPSC 51161572 Nivimedone sodium anhydrous is a Commodity-tier code for a pharmaceutical active ingredient with no recent state and local procurement activity in the available record.

No representative state and local opportunities appear to be soliciting under this code currently. The absence of recent activity suggests either minimal or specialized demand among state and local health systems, pharmacy benefit programs, and medical supply chains, or that relevant procurements are being classified under broader pharmaceutical family or class codes rather than this specific ingredient designation.